SCHEMBL4435193

SCHEMBL4435193

CC(C)(C)OC(=O)ON1CC(N)C(O)C1

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
NR1H2 P55055 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8329981 0.88 CHRM2 (0.37) CHRM2CHRM1CHRM3NR1H2
SCHEMBL8329335 0.88 CHRM2 (0.37) CHRM2CHRM1CHRM3NR1H2
SCHEMBL8811085 0.83 HSD17B10 (0.33) CHRM2CHRM1CHRM3
SCHEMBL8124000 0.83 HSD17B10 (0.33) CHRM2CHRM1CHRM3
SCHEMBL4435738 0.82 CHRM2 (0.32) CHRM2CHRM1CHRM3
SCHEMBL14764516 0.80 CHRM2 (0.41) CHRM2CHRM1CHRM3NR1H2
SCHEMBL8327110 0.74 NR1H2 (0.33) CHRM2CHRM1CHRM3NR1H2
SCHEMBL8329771 0.74 NR1H2 (0.33) CHRM2CHRM1CHRM3NR1H2
SCHEMBL4584160 0.74 CHRM2 (0.35) CHRM2CHRM1CHRM3NR1H2
SCHEMBL4440743 0.73 CTSK (0.33) CHRM2CHRM1CHRM3NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132193-B1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS BOEHRINGER INGELHEIM INT (DE) 2012-10-24 EP disclosed
EP-2132193-A1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS Boehringer Ingelheim International GmbH (DE) 2009-12-16 EP disclosed
WO-2008116881-A1 SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-10-02 WO disclosed
EP-1975165-A1 Substituted pyrrolidinamides, their production and utilisation as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2008-10-01 EP disclosed